Common Equity: The sum of all common equity items.
CASI Pharmaceuticals Inc. (CASI) had Common Equity of $-8.07M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$6.24M |
|
$-10.75M |
|
$2.62M |
|
$3.62M |
|
$16.62M |
|
$-10.38M |
|
$-0.37M |
|
$-10.75M |
|
$-10.75M |
|
$-10.75M |
|
$-10.75M |
|
$-10.75M |
|
$-10.75M |
|
$-10.38M |
|
$-10.38M |
|
15.49M |
|
15.49M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$27.16M |
|
$7.66M |
|
$13.66M |
|
$40.82M |
|
$33.71M |
|
-- |
|
$15.18M |
|
$48.89M |
|
|
Common Equity |
$-8.07M |
$-8.30M |
|
$-8.07M |
|
15.49M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.81 |
|
-- |
|
-- |
|
-- |
|
-2.29 |
|
58.00% |
|
-166.33% |
|
-166.33% |
|
-- |
|
-172.28% |
|
-172.28% |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.63 |
|
0.82 |
|
109.62 |
|
133.21% |
|
129.47% |
|
-26.33% |
|
133.21% |
|
$-0.52 |
|
-- |
|
-- |
|